Journal profile
Journal of Medical Microbiology and Infectious Diseases
ISSN 2345-5349 · eISSN 2345-5330 · Pasteur Institute of Iran · Iran, Islamic Republic of
Journal of Medical Microbiology and Infectious Diseases: diamond open access (no APC); no APC; review about 90 days (submission to acceptance, publisher); 0 articles in 2025.
Scope
Aims, scope and focus
Journal of Medical Microbiology and Infectious Diseases is published by Pasteur Institute of Iran. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Research on Leishmaniasis Studies and COVID-19 Clinical Research Studies, together about 26.5% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
JoMMID aims to disseminate high-quality research and advance knowledge in the fields of medical microbiology, infectious diseases, and related disciplines. We welcome submissions of original research articles, mini-reviews/full reviews, systematic reviews, meta-analyses, short communications/reports, case reports, letters to the editor, and commentaries that demonstrate scientific rigor, ethical integrity, and clinical relevance. The journal's scope encompasses, but is not limited to: Infectious diseases epidemiology and public health Emerging and re-emerging pathogens Advanced diagnostic techniques for human and animal infections Antimicrobial resistance mechanisms and novel therapeutic approaches Molecular epidemiology and genomic surveillance of pathogens Host-pathogen interactions and host susceptibility factors Immunology of infectious diseases and vaccine development Microbial pathogenesis and virulence mechanisms Vector-borne and zoonotic diseases One Health approaches to infectious diseases Environmental microbiology and its impact on health Microbiome studies in health and disease
From the journal's Aims & Scope
Editor-in-chief Azam BolhassaniPublisher website
Editorial board by country: none in mainland China; most named Iran 35, Malaysia 2, United States 1, France 1 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology14.8%
- Research on Leishmaniasis StudiesMedicine6.1%
- COVID-19 Clinical Research StudiesMedicine5.7%
- Antibiotic Use and ResistanceImmunology and Microbiology5.7%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.8%
- Urinary Tract Infections ManagementMedicine4.8%
- Brucella: diagnosis, epidemiology, treatmentVeterinary4.8%
- Antimicrobial Resistance in StaphylococcusMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, Islamic World Science Citation Center (ISC), Scientific Information Database (SID), Magiran
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 8OpenAlex ·
- i10-index
- 4OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 163 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 38 |
| 2025 | 0 | 0 | 55 |
| 2024 | 0 | 0 | 76 |
| 2023 | 8 | 8 | 63 |
| 2022 | 33 | 33 | 47 |
| 2021 | 32 | 32 | 44 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
90 dayssubmission to acceptance · community reports about 12 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to final decision
- 30 daysPublisher website ·
- Submission to acceptance
- 90 daysPublisher website ·
- Acceptance to publication
- 90 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted7, with length limits
- case reportmpleted CARE checklist with submission. Case Reports should adhere to the following guidelines: The main text should not exceed 1200 words, excluding the figure…main text ≤ 1,200 words
- commentaryions for research or clinical practice. Commentaries should adhere to the following guidelines: The main text should be approximately 1000 words, excluding refe…main text ≤ 1,000 words
- mini reviewnts. For instance, concise formats like Mini Reviews or Critically Appraised Topics may lean toward the lower end (around 4,000 words), while comprehensive revi…main text ≤ 4,000 words
- original articlesis of the results. The main text of an Original Article should not exceed 6000 words, excluding tables, figures, and references. Abstracts mustmain text ≤ 6,000 words
- reviewround 4,000 words), while comprehensive reviews like Systematic Reviews or Umbrella Reviews may approach the higher end (up to 8,000 words). The main text shoul…main text ≤ 8,000 words
- review articleMeta-analysis, etc.). The main text of review articles should generally be between 4,000 and 8,000 words, excluding figures, tables, and references, with the sp…main text ≤ 8,000 words
- short communicationre condensed format. The main text of a Short Communication should not exceed 2500 words, excluding tables, figures, and references. Abstracts mustmain text ≤ 2,500 words
Policy excerpts from the journal's websiteAI use, Authorship, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use
AI use must be disclosed; AI cannot be an author Model summary
Authors must disclose the use of AI-based tools (e.g., language models, chatbots, or image generation tools) in the preparation of their manuscript, including writing, data analysis, or figure creation. AI tools cannot be listed as authors, as they do not meet ICMJE authorship criteria.
Source ↗Publisher website ·- Authorship Authorship Disputes
JoMMID recognizes that authorship disputes can arise during the research and publication process. We are committed to resolving such disputes fairly and efficiently, following the guidelines and recommendations of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE). Preventing Authorship Disputes: Early Agreement: Authors are encouraged to …
Source ↗Publisher website ·- Publication ethics
Adheres to ICMJE and COPE guidelines Model summary
JoMMID is committed to upholding the highest standards of ethical conduct in research and publication. We adhere to the guidelines and recommendations of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- License & copyright
Copyright Transfer Agreement required upon acceptance Model summary
Upon acceptance of a manuscript for publication, authors will be asked to sign a Copyright Transfer Agreement (CTA) that grants JoMMID the exclusive right to publish and distribute the article in all formats (print and electronic).
Source ↗Publisher website ·- Open access
Peer-reviewed, open-access quarterly publication Model summary
The Journal of Medical Microbiology and Infectious Diseases (JoMMID) is a peer-reviewed, open-access quarterly publication of the Pasteur Institute of Iran.
Source ↗Publisher website ·- Peer review
Exclusive submission required Model summary
Manuscripts submitted to the Journal of Microbiology and Infectious Diseases (JoMMID) must not be under consideration for publication elsewhere, nor can they be submitted to another journal until the final outcome of the review process has been determined by JoMMID.
Source ↗Publisher website ·- Trial registration / reporting guidelines
Clinical trial registration required Model summary
All clinical trials must be registered in a publicly accessible registry (e.g., ClinicalTrials.gov, WHO ICTRP) before the first participant is enrolled.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pasteur Institute of Iran
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2345-5349
- Electronic ISSN
- 2345-5330
- Latest issue on the website
- Volume 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Medical Microbiology and Infectious Diseases
How long does peer review take at Journal of Medical Microbiology and Infectious Diseases?
The publisher reports about 90 days (submission to acceptance); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Medical Microbiology and Infectious Diseases based?
Of the 39 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (35), Malaysia (2) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Medical Microbiology and Infectious Diseases?
According to LetPub and DOAJ records, Journal of Medical Microbiology and Infectious Diseases is indexed in DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Journal of Medical Microbiology and Infectious Diseases open access, and what is the APC?
Journal of Medical Microbiology and Infectious Diseases is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .